Gao Jinghai, Dang Jianhong, Chu Jing, Liu Xiaojun, Wang Jing, You Jiahao, Jin Zhijun
Department of Obstetrics and Gynecology, Shanghai ChangZheng Hospital, Naval Medical University, Shanghai, 200003, People's Republic of China.
Cancer Manag Res. 2021 Apr 21;13:3485-3492. doi: 10.2147/CMAR.S299827. eCollection 2021.
To compare perioperative outcomes between robotic single-site surgical technique and conventional laparoendoscopic single-site surgical technique.
This was a retrospective cohort study involving 67 patients who received robotic single-site surgery or laparoendoscopic single-site surgery for the treatment of stage IB1 cervical squamous carcinoma. The robotic single-site radical hysterectomy technique combined with pelvic lymph node dissections were performed in 32 patients while the laparoendoscopic single-site radical hysterectomy technique combined with pelvic lymph node dissections were performed in 35 patients.
The enrolled patients had been diagnosed with stage IB1 cervical squamous carcinoma. The perioperative outcomes were mean age (51.63±8.32 years in the lymph node dissection (RSS group) and 53.14±8.14 years in the lymph node dissection (LESS group), p=0.453); BMIs (23.76±2.72 in the RSS group and 23.46±2.28 in the LESS group, p=0.629); shorter operative times (223.56±15.43 min in the RSS group and 248.61±20.89 min in the LESS group, p<0.01) and less estimated blood loss (217.25±16.77 mL in the RSS group and 294.74±24.00 mL in the LESS group, p<0.01). None of the study participants exhibited postoperative pain. There were no statistically significant differences in the length of hospital stay (p=0.865), perioperative complications (p=0.602), duration of closure and removal of catheter (p=0.518) as well as in pathological diagnoses between the two groups.
Robotic single-site surgery can be used in the treatment of early stage cervical cancer as it exhibits acceptable operative times and perioperative outcomes. This surgical technique is feasible and safe.
比较机器人单孔手术技术与传统腹腔镜单孔手术技术的围手术期结果。
这是一项回顾性队列研究,纳入了67例接受机器人单孔手术或腹腔镜单孔手术治疗IB1期宫颈鳞状细胞癌的患者。32例患者接受了机器人单孔根治性子宫切除术联合盆腔淋巴结清扫术,35例患者接受了腹腔镜单孔根治性子宫切除术联合盆腔淋巴结清扫术。
纳入患者均被诊断为IB1期宫颈鳞状细胞癌。围手术期结果为平均年龄(淋巴结清扫组机器人单孔手术组(RSS组)为51.63±8.32岁,淋巴结清扫组腹腔镜单孔手术组(LESS组)为53.14±8.14岁,p = 0.453);体重指数(RSS组为23.76±2.72,LESS组为23.46±2.28,p = 0.629);手术时间较短(RSS组为223.56±15.43分钟,LESS组为248.61±20.89分钟,p<0.01)且估计失血量较少(RSS组为217.25±16.77毫升,LESS组为294.74±24.00毫升,p<0.01)。所有研究参与者均未出现术后疼痛。两组在住院时间(p = 0.865)、围手术期并发症(p = 0.602)、导管闭合和拔除时间(p = 0.518)以及病理诊断方面均无统计学显著差异。
机器人单孔手术可用于早期宫颈癌的治疗,因为其手术时间和围手术期结果均可接受。该手术技术可行且安全。